AbbVie execs touted a wave of Rinvoq programs at Cowen’s annual conference on healthcare Tuesday as they brace for a tougher Humira battle in the second half of this year.
Since its first approval in rheumatoid arthritis in 2002, Humira became one of industry’s top sellers ever, adding a...
